1. Home
  2. ABEO vs TG Comparison

ABEO vs TG Comparison

Compare ABEO & TG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABEO
  • TG
  • Stock Information
  • Founded
  • ABEO 1974
  • TG 1988
  • Country
  • ABEO United States
  • TG United States
  • Employees
  • ABEO N/A
  • TG N/A
  • Industry
  • ABEO Biotechnology: Pharmaceutical Preparations
  • TG Metal Fabrications
  • Sector
  • ABEO Health Care
  • TG Industrials
  • Exchange
  • ABEO Nasdaq
  • TG Nasdaq
  • Market Cap
  • ABEO 256.9M
  • TG 301.0M
  • IPO Year
  • ABEO 1980
  • TG 1989
  • Fundamental
  • Price
  • ABEO $6.59
  • TG $8.82
  • Analyst Decision
  • ABEO Strong Buy
  • TG
  • Analyst Count
  • ABEO 6
  • TG 0
  • Target Price
  • ABEO $18.00
  • TG N/A
  • AVG Volume (30 Days)
  • ABEO 1.2M
  • TG 80.8K
  • Earning Date
  • ABEO 08-11-2025
  • TG 08-06-2025
  • Dividend Yield
  • ABEO N/A
  • TG N/A
  • EPS Growth
  • ABEO N/A
  • TG N/A
  • EPS
  • ABEO N/A
  • TG N/A
  • Revenue
  • ABEO N/A
  • TG $617,839,000.00
  • Revenue This Year
  • ABEO N/A
  • TG N/A
  • Revenue Next Year
  • ABEO $322.37
  • TG N/A
  • P/E Ratio
  • ABEO N/A
  • TG N/A
  • Revenue Growth
  • ABEO N/A
  • TG 17.42
  • 52 Week Low
  • ABEO $3.93
  • TG $4.87
  • 52 Week High
  • ABEO $7.32
  • TG $9.43
  • Technical
  • Relative Strength Index (RSI)
  • ABEO 66.16
  • TG 57.26
  • Support Level
  • ABEO $5.66
  • TG $8.82
  • Resistance Level
  • ABEO $5.99
  • TG $9.11
  • Average True Range (ATR)
  • ABEO 0.26
  • TG 0.24
  • MACD
  • ABEO 0.09
  • TG -0.02
  • Stochastic Oscillator
  • ABEO 76.92
  • TG 53.95

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

About TG Tredegar Corporation

Tredegar Corp, through its subsidiaries, engages in the manufacture of polyethylene plastic films, polyester films, and aluminum extrusions. Polyethylene plastic films produce plastic films, elastics, and laminate materials that are used in personal care products, surface protection films, and specialty and optical lighting applications. The company operates through segments including PE films, flexible packaging films, and aluminum extrusions. Aluminum extrusions generate the majority of revenue and provide high-quality, soft-alloy, medium-strength aluminum utilized in the building and construction, automotive, consumer durables, machinery and equipment, electrical, and distribution markets. Revenue is generated from the United States, Asia, and Brazil.

Share on Social Networks: